Dr. Henry (Joe) Henk specializes in health economics, econometrics and health outcomes with particular focus on research in oncology and the use of biologics. Since joining Optum in 2004, his research has spanned a variety of disease and drug areas and has focused on therapy compliance, burden of illness and cost comparisons.
See Henry (Joe) Henk, Ph.D.'s bio 